BioGlyco supplement products (including BioGlyco Flow, BioGlyco Capsules, and BioGlyco Blood) are not affiliated with CD BioGlyco.
CD BioGlyco does not manufacture, distribute, or provide after-sales support for these consumer products. For any product-related questions, please contact the original seller directly.
PF-562271, soluble in warmed DMSO and insoluble in water and ethanol, is a FAK inhibitor that is used to block angiogenesis in diseases such as cancer. It targets CDK2/CyclinE, PYK2, Abl, Aurora A, c-Src, CDK1/CyclinB, CDK2/CyclinA, CDK3/CyclinE, CDK4, and CDK5/p35.
PF-562271 serves as a tool in understanding the role of FAK in promoting cancer cell survival and proliferation and its potential as a therapeutic target.
Publications
Publications (0)
×
Publications
Thank you for choosing our products for your research. By sharing your publications or experimental feedback, you provide invaluable insights that help fellow scientists accelerate their discoveries. Your contribution also drives our commitment to continuous product optimization.
As a token of our appreciation, verified submissions will receive an exclusive discount code for your next order.
*Submitted research data and images may be featured on our product pages. We strictly protect your personal privacy; no sensitive contact information will ever be disclosed.
CD BioGlyco is a leading biotechnology company specializing in glycobiology. We deliver high-quality products and services to support cutting-edge research worldwide.